A pilot trial of pioglitazone HCl and tretinoin in ALS: Cerebrospinal fluid biomarkers to monitor drug efficacy and predict rate of disease progression

Neurology Research International

Volumn 2012, Issue , 2012, Pages

  Levine, Todd D ^a   Bowser, Robert ^b   Hank, Nicole C ^a   Gately, Stephen ^c   Stephan, Dietrich ^d   Saperstein, David S ^a   Van Keuren Jensen, Kendall ^c  

^a Phoenix Neurological Associates   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^d Silicon Valley Biosystems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866163028     PISSN: 20901852     EISSN: 20901860     Source Type: Journal    
DOI: 10.1155/2012/582075     Document Type: Article

References (19)

1. Chiò A, Schymick J. C., Restagno G., Scholz S. W., Lombardo F., A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Human Molecular Genetics 2009 18 8 1524 1532
2. Dunckley T., Huentelman M. J., Craig D. W., Pearson J. V., Szelinger S., Joshipura K., Halperin R. F., Stamper C., Jensen K. R., Letizia D., Hesterlee S. E., Pestronk A., Levine T., Bertorini T., Graves M. C., Mozaffar T., Jackson C. E., Bosch P., McVey A., Dick A., Barohn R., Lomen-Hoerth C., Rosenfeld J., O'Connor D. T., Zhang K., Crook R., Ryberg H., Hutton M., Katz J., Simpson E. P., Mitsumoto H., Bowser R., Miller R. G., Appel S. H., Stephan D. A., Whole-genome analysis of sporadic amyotrophic lateral sclerosis. The New England Journal of Medicine 2007 357 8 775 788 2-s2.0-34548083742 10.1056/NEJMoa070174 (Pubitemid 47295644)
3. Dangond F., Hwang D., Camelo S., Pasinelli P., Frosch M. P., Stephanopoulos G., Stephanopoulos G., Brown R. H., Gullans S. R., Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiological Genomics 2004 16 229 239 2-s2.0-1442282943 10.1152/physiolgenomics.00087.2001 (Pubitemid 38420040)
4. Jiang Y. M., Yamamoto M., Kobayashi Y., Yoshihara T., Liang Y., Terao S., Takeuchi H., Ishigaki S., Katsuno M., Adachi H., Niwa J. I., Tanaka F., Doyu M., Yoshida M., Hashizume Y., Sobue G., Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Annals of Neurology 2005 57 2 236 251 2-s2.0-19944432585 10.1002/ana.20379 (Pubitemid 40179862)
5. Corcoran J., So P. L., Maden M., Absence of retinoids can induce motoneuron disease in the adult rat and a retinoid defect is present in motoneuron disease patients. Journal of Cell Science 2002 115 24 4735 4741 2-s2.0-0037115496 10.1242/jcs.00169 (Pubitemid 36054628)
6. Malaspina A., Kaushik N., De Belleroche J., A 14-3-3 mRNA is up-regulated in amyotrophic lateral sclerosis spinal cord. Journal of Neurochemistry 2000 75 6 2511 2520 2-s2.0-0033777919 10.1046/j.1471-4159.2000.0752511.x
7. Ryberg H., An J., Darko S., Lustgarten J. L., Jaffa M., Gopalakrishnan V., Lacomis D., Cudkowicz M., Bowser R., Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle and Nerve 2010 42 1 104 111 2-s2.0-77954122515 10.1002/mus.21683
8. Kolarcik, Christi L., Beyond Biomarker Discovery: Retinoid Signaling in Motor Neurons and Amyotrophic Lateral Sclerosis 2010 Doctoral Dissertation, University of Pittsburgh
9. Mey J., New therapeutic target for CNS injury? The role of retinoic acid signaling after nerve lesions. Journal of Neurobiology 2006 66 7 757 779 2-s2.0-33745317579 10.1002/neu.20238 (Pubitemid 43939198)
10. Schintu N., Frau L., Ibba M., Caboni P., Garau A., Carboni E., Carta A. R., PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease. European Journal of Neuroscience 2009 29 5 954 963 2-s2.0-61449237400 10.1111/j.1460-9568.2009.06657.x
11. Schütz B., Reimann J., Dumitrescu-Ozimek L., Kappes-Horn K., Landreth G. E., Schürmann B., Zimmer A., Heneka M. T., The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice. Journal of Neuroscience 2005 25 34 7805 7812 2-s2.0-23944490153 10.1523/JNEUROSCI.2038-05.2005 (Pubitemid 41208652)
12. Brettschneider J., Petzold A., Sümuth S. D., Ludolph A. C., Tumani H., Axonal damage markers in cerebrospinal fluid are increased in ALS. Neurology 2006 66 6 852 856 2-s2.0-33645800776 10.1212/01.wnl.0000203120.85850.54 (Pubitemid 43739759)
13. Mares J., Kanovsky P., Herzig R., Stejskal D., Vavrouskova J., Hlustik P., Vranova H., Burval S., Zapletalova J., Pidrman V., Obereigneru R., Suchy A., Vesely J., Podivinsky J., Urbanek K., The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid: Laboratory markers of neurodegenerative diseases. Neurological Sciences 2009 30 1 1 7 2-s2.0-58249115299 10.1007/s10072-008-0005-7
14. Süssmuth S. D., Tumani H., Ecker D., Ludolph A. C., Amyotrophic lateral sclerosis: disease stage related changes of tau protein and S100 beta in cerebrospinal fluid and creatine kinase in serum. Neuroscience Letters 2003 353 1 57 60 2-s2.0-17544398505 10.1016/j.neulet.2003.09.018 (Pubitemid 37464619)
15. Wild E. J., Petzold A., Keir G., Tabrizi S. J., Plasma neurofilament heavy chain levels in Huntington's disease. Neuroscience Letters 2007 417 3 231 233 2-s2.0-34247168504 10.1016/j.neulet.2007.02.053 (Pubitemid 46589785)
16. Wong B. S., Pan T., Liu T., Li R., Gambetti P., Sy M. S., Differential contribution of superoxide dismutase activity by prion protein in vivo. Biochemical and Biophysical Research Communications 2000 273 1 136 139 2-s2.0-0034709641 10.1006/bbrc.2000.2911 (Pubitemid 30426875)
17. Ganesalingam J., An J., Shaw C. E., Shaw G., Lacomis D., Bowser R., Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. Journal of Neurochemistry 2011 117 3 528 537 2-s2.0-79954414960 10.1111/j.1471-4159.2011.07224.x
18. Reijn T. S., Abdo W. F., Schelhaas H. J., Verbeek M. M., CSF neurofilament protein analysis in the differential diagnosis of ALS. Journal of Neurology 2009 256 4 615 619 2-s2.0-67349126209 10.1007/s00415-009-0131-z
19. Levine T. D., Bowser R., Hank N., Saperstein D., A pilot trial of memantine and riluzole in ALS: correlation to CSF biomarkers. Amyotrophic Lateral Sclerosis 2010 11 6 514 519 2-s2.0-78649351936 10.3109/17482968.2010. 513052